Combination of saikosaponin c and telbivudine synergistically enhances the anti-HBV activity

ConclusionThese in vitro results indicated that SSc acted as a promising nucleoside analogue adjuvant, especially for telbivudine in the therapeutic strategies against HBV infection.
Source: Inflammation Research - Category: Research Source Type: research
More News: Research | Study